Concussion Market Introduction and Overview
According to SPER Market Research, the Global Concussion Market is estimated to reach USD 12.06 billion by 2034 with a CAGR of 6.25%.
The report includes an in-depth analysis of the Global Concussion Market, including market size and trends, product mix, Applications, and supplier analysis. The global concussion market was valued at USD 6.99 billion in 2025 and is predicted to increase at a CAGR of 6.25% between 2025 and 2034. The rising number of mild traumatic brain injuries (TBIs) is a major driver of market expansion. Furthermore, the increasing number of concussion awareness programs is likely to drive market growth even further. Other market drivers include advances in diagnostic technology, such as portable concussion assessment equipment, and the growing use of digital health solutions for remote monitoring and follow-up care.
By Assessment and Treatment Insights: The diagnosis segment led the market with the highest revenue share in 2024 and is expected to grow significantly in the future. This growth is influenced by better diagnostic technologies and more concussion cases. Important tools include CT scans, MRIs, EEGs, and new methods. The segment is also supported by increased research aimed at improving diagnostic accuracy, with many clinical trials ongoing to evaluate different methods.
By End Use Insights: The hospital segment had the biggest market share in 2024, fueled by increased awareness of concussion risks and hospitals' dedication to advanced diagnostic and treatment options. Many hospitals are using new methods to improve concussion care and are working to enhance their knowledge in this area. For example, in September 2023, experts at the Ottawa Hospital launched the Living Concussion Guidelines for healthcare professionals.
By Regional Insights: North America's concussion market held a substantial revenue share in 2024 and controlled the global market as a whole. Rising sports participation, improved mental health awareness, technological and diagnostic breakthroughs, legislative changes, and heightened knowledge of concussion hazards are all contributing factors to the region's growth. A number of states in the US have proposed laws mandating that schools establish concussion management procedures, which include ordering players to be pulled from games when a concussion is suspected.
Market Competitive Landscape:
The market is competitive, with huge multinationals such as Johnson & Johnson, KLS Martin Group, and Medtronic plc dominating innovation and product portfolios. Regional enterprises and new entrants, particularly those from Asia-Pacific are also making substantial progress. The market is characterized by regular technology developments, such as enhanced imaging systems, the use of advanced treatments, and user-friendly designs, which drive continuous product development. Companies frequently form strategic partnerships, mergers, and acquisitions in order to extend their market reach and technological capabilities.
Recent Developments:
The Philips CT 5300 system, which has sophisticated AI capabilities and is intended for use in screening, interventional treatments, and diagnostics, was introduced by Philips in February 2024. The corporation may benefit from a larger consumer base as a result of this product launch. In July 2024, Oculogica announced that Health Canada approved the EyeBOX concussion diagnostic device. This tool will help healthcare providers diagnose concussions, marking a significant milestone for EyeBOX, now accessible to professionals in Canada for assessing mTBIs. In December 2023, Integra LifeSciences Holdings Corporation announced that it has finalized an agreement to acquire Acclarent, Inc. from Ethicon, Inc. for USD 275 million in cash, with possible adjustments and an extra USD 5 million for regulatory milestones.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Assessment and Treatment, By End Use. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | NIHON KOHDEN CORPORATION, Compumedics Limited, INTEGRA LIFESCIENCES, BioDirection (NanoDx), Oculogica, Abbott, BrainScope Company Inc, BIOMÉRIEUX, Magstim, Advanced Brain Monitoring, Inc, Healius Limited. |
Key Topics Covered in the Report:
- Global Concussion Market Size (FY’2021-FY’2034)
- Overview of Global Concussion Market
- Segmentation of Global Concussion Market By Assessment And Treatment (Treatment, Diagnosis)
- Segmentation of Global Concussion Market By End Use (Hospitals, Diagnostic centers, Neurologic clinics, Research centers, Others)
- Statistical Snap of Global Concussion Market
- Expansion Analysis of Global Concussion Market
- Problems and Obstacles in Global Concussion Market
- Competitive Landscape in the Global Concussion Market
- Details on Current Investment in Global Concussion Market
- Competitive Analysis of Global Concussion Market
- Prominent Players in the Global Concussion Market
- SWOT Analysis of Global Concussion Market
- Global Concussion Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Concussion Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Concussion Market
7. Global Concussion Market, By Assessment and Treatment (USD Million) 2021-2034
7.1. Treatment
7.2. Diagnosis
7.2.1. CT
7.2.2. MRI
7.2.3. EEG
7.2.4. Others
8. Global Concussion Market, By End Use (USD Million) 2021-2034
8.1. Hospitals
8.2. Diagnostic centers
8.3. Neurologic clinics
8.4. Research centers
8.5. Others
9. Global Concussion Market (USD Million) 2021-2034
9.1. Global Concussion Market Size and Market Share
10. Global Concussion Market, By Region, (USD Million) 2021-2034
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5. Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. NIHON KOHDEN CORPORATION
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Compumedics Limited
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. INTEGRA LIFESCIENCES
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Bio Direction (NanoDx)
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Oculogica
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Abbott
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. BrainScope Company Inc
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. BIOMERIEUX
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Magstim
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Advanced Brain Monitoring, Inc
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
